The FDA has granted 510(k) clearance to Pulse Biosciences Inc's (NASDAQ: PLSE) CellFX System, expanding the indication for use to include the treatment of sebaceous hyperplasia in patients with ...

The pivotal study is designed to compare the safety and efficacy of the CellFX System against electrodesiccation procedures in clearing facial sebaceous hyperplasia lesions. About 60 patients ...

Please provide your email address to receive an email when new articles are posted on . Pulse Biosciences has announced it received FDA 510(k) clearance for expanding the use of its CellFX System ...

Milia, closed comedones, sebaceous hyperplasia, and keratosis pilaris are common culprits, each requiring different approaches. Gentle exfoliation, appropriate skincare, and professional help when ...